Searched for
PEGIHEP
Zydus Cadila seeks DCGI nod for use of hepatitis drug for treating coronavirus casesThe interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complicatio...- Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in IndiaIndia's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following pro...
- COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapyThe company had completed the phase 2 clinical trials with PegiHep last month. In a regulatory filing, Zydus Cadila said it has received ap...
- Vaccines that can help India in its fight against Covid-19Experts have said that vaccines like Pfizer that requires super-cold storage may not be ideal for India and will pose a logistical hurdle.
- Zydus Cadila completes phase 2 clinical trial in COVID-19 patients with biological therapy PegiHepIn a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological ...
- Search for vaccines hots up as Covid-19 continues to spread and wreak havoc around the worldOxford University and AstraZeneca will be sharing their data from phase-I trial of their much-touted Covid-19 vaccine candidate on July 20....
- Zydus Cadila gets nod from Mexican authority for clinical trials of COVID-19 therapyIn a regulatory filing, Zydus Cadila said it had received approval from the Mexican regulatory authority Cofepris to conduct clinical trial...
- Hold Cadila Healthcare, target price Rs 328: Anand RathiThe brokerage expects Cadila to report an ~8% year on year decline in revenue to Rs 34 billion.
- Zydus Cadila takes a shot at old Hepatitis C injection to treat Covid-19Ahmedabad-based Zydus has initiated talks with the Department of Biotechnology for a compassionate trial. It is also working with the USFDA...
- Cadila Healthcare Q3 net dips by 4.4%, sales rise 20%Cadila Healthcare, the flagship company of Zydus group, has suffered a 4.4% drop in its third quarter net profit on account of forex losses.
Load More
